Aspira Women’s Health (AWH) – Press Releases
-
Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
-
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
-
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
-
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference
-
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President
-
Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024
-
Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
-
Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)
-
Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines
-
Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement
-
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
-
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024
-
Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
-
New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT
-
New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
-
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
-
Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)
-
Aspira Women’s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)
-
Aspira Women’s Health Reports Third Quarter 2023 Financial Results
-
Aspira Women’s Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch
-
Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Monday, November 13, 2023
-
Aspira Women’s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research
-
Aspira Women’s Health Establishes a New Clinical Advisory Board
-
New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT
-
Aspira Women’s Health to Present at the BioVenture Nexus Conference
-
Aspira Women’s Health Regains Nasdaq Compliance
-
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
-
Aspira Women’s Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
-
Aspira Women’s Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference
-
Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
-
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
-
Aspira Women’s Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer
-
Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
-
Aspira Women’s Health Announces $4.7 Million Registered Direct Offering
-
Aspira Women’s Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD
-
New to The Street Announces Five Corporate Interviews on its 478th Show, Airing on the Fox Business Network, Tonight, Monday, June 12, 2023, at 10:30 PM PT
-
New to The Street TV Announces its Four Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT
-
Aspira Women’s Health Appoints Dr. Winfred Parnell to its Board of Directors
-
New to The Street Announces its Corporate Guests TV Interviews, Airing as Episodes 474 and 475 with Shows Starting on Saturday, June 3, 2023, at 3:30 PM ET
-
Aspira Women’s Health Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
-
Aspira Women’s Health Announces the Publication of Three Abstracts by the American Society of Clinical Oncology (ASCO) Supporting the Clinical Utility of OvaSuite(SM) Ovarian Cancer Risk Assessment
-
Aspira Women’s Health to Participate at William Blair’s 43rd Annual Growth Stock Conference
-
New to The Street Announces the Televised Lineups for Shows 471, 472, and 473; Airings on Three Networks Will Begin on Saturday, May 27, 2023, at 3:30 PM ET
-
New to The Street Announces its Televised Corporate Interviews Airing on Newsmax and The FOX Business Network, Episodes 469 and 470; Broadcastings Begin Saturday, May 20, 2023, at 3:30 PM ET
-
Aspira Women’s Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference
-
Aspira Women’s Health Names Torsten Hombeck as Chief Financial Officer
-
Aspira Women’s Health to Host Investor Day on OvaWatch(SM) and EndoCheck™ Market Opportunities on May 23, 2023
-
Aspira Women’s Health launches its New to The Street Media Series on May 8, 2023, World Ovarian Cancer Day
-
Aspira Women’s Health® Reports First Quarter 2023 Financial Results
-
Aspira Women’s Health Announces 1-for-15 Reverse Stock Split
Back to AWH Stock Lookup
